Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target vol...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3eb53e756c64862a665a4a1c30cdbcb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a3eb53e756c64862a665a4a1c30cdbcb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a3eb53e756c64862a665a4a1c30cdbcb2021-12-02T11:36:21ZPatient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)10.1038/s41598-021-85031-w2045-2322https://doaj.org/article/a3eb53e756c64862a665a4a1c30cdbcb2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85031-whttps://doaj.org/toc/2045-2322Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target volume (ITV) was defined including different numbers of phases picked from a 4D Computed tomography (CT) defining the gating window (gw). Planning target volume (PTV) reductions depending on the gw were analyzed. A treatment plan was calculated on a reference phase CT (rCT) and the dose for each breathing phase was calculated and accumulated on the rCT. We compared the dosimetric results with the dose calculated when all breathing phases were included for ITV definition. GWs including 1 to 10 breathing phases were analyzed. We found PTV reductions up to 38.4%. The mean reduction of the lung volume receiving 20 Gy due to gating was found to be 25.7% for peripheral tumors and 16.7% for central tumors. Gating considerably reduced esophageal doses. However, we found that simple reduction of the gw does not necessarily influence the dose in a clinically relevant range. Thus, we suggest a patient individual definition of the breathing phases included within the gw.K. M. KrausM. OechsnerJ. J. WilkensK. A. KesselS. MünchS. E. CombsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q K. M. Kraus M. Oechsner J. J. Wilkens K. A. Kessel S. Münch S. E. Combs Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC) |
description |
Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target volume (ITV) was defined including different numbers of phases picked from a 4D Computed tomography (CT) defining the gating window (gw). Planning target volume (PTV) reductions depending on the gw were analyzed. A treatment plan was calculated on a reference phase CT (rCT) and the dose for each breathing phase was calculated and accumulated on the rCT. We compared the dosimetric results with the dose calculated when all breathing phases were included for ITV definition. GWs including 1 to 10 breathing phases were analyzed. We found PTV reductions up to 38.4%. The mean reduction of the lung volume receiving 20 Gy due to gating was found to be 25.7% for peripheral tumors and 16.7% for central tumors. Gating considerably reduced esophageal doses. However, we found that simple reduction of the gw does not necessarily influence the dose in a clinically relevant range. Thus, we suggest a patient individual definition of the breathing phases included within the gw. |
format |
article |
author |
K. M. Kraus M. Oechsner J. J. Wilkens K. A. Kessel S. Münch S. E. Combs |
author_facet |
K. M. Kraus M. Oechsner J. J. Wilkens K. A. Kessel S. Münch S. E. Combs |
author_sort |
K. M. Kraus |
title |
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC) |
title_short |
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC) |
title_full |
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC) |
title_fullStr |
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC) |
title_full_unstemmed |
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC) |
title_sort |
patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (nsclc) |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/a3eb53e756c64862a665a4a1c30cdbcb |
work_keys_str_mv |
AT kmkraus patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc AT moechsner patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc AT jjwilkens patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc AT kakessel patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc AT smunch patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc AT secombs patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc |
_version_ |
1718395778814181376 |